2024/03/28 17:32:20 | |
---|---|
Price | |
28.455 EUR | |
Difference | 1.64% (0.46) |
ISIN | DE000BAY0017 |
Symbol | BAYN |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 27,930 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 28.315 EUR (300) |
Ask (Ask size) | 28.59 EUR (300) |
Open | 28.54 EUR |
High | 28.54 EUR |
Low | 28.455 EUR |
Close (prev. day) | 27.995 EUR |
VWAP | 28.475385 EUR |
Volume (pcs) | 325 |
Trading volume | 9,254.50 |
Number of trades | 3 |
Last size | 0 |
Related Futures | 53 |
Related Options | - |
Date | Headline | Download | |
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings | ||
2023/12/07 | Global Equity Ratings | ||
2023/11/24 | Global Equity Ratings | ||
2023/10/27 | Global Equity Ratings |
2024/03/28 17:32:20 | |
---|---|
Price | |
28.455 EUR | |
Difference | 1.64% (0.46) |
ISIN | DE000BAY0017 |
Symbol | BAYN |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 27,930 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 28.315 EUR (300) |
Ask (Ask size) | 28.59 EUR (300) |
Open | 28.54 EUR |
High | 28.54 EUR |
Low | 28.455 EUR |
Close (prev. day) | 27.995 EUR |
VWAP | 28.475385 EUR |
Volume (pcs) | 325 |
Trading volume | 9,254.50 |
Number of trades | 3 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -37.21% | -49.98% | -46.48% |
Perf (abs.) | -16.86 | -28.44 | -24.72 |
Beta | 1.24 | 1.09 | 0.77 |
Volatility | 38.88 | 31.55 | 29.12 |
Ø price 5 days | Ø volume 5 days (pcs.) | 27.436 EUR (637) |
Ø price 30 days | Ø volume 30 days (pcs.) | 27.387 EUR (758) |
Ø price 100 days | Ø volume 100 days (pcs.) | 31.337 EUR (696) |
Ø price 250 days | Ø volume 250 days (pcs.) | 43.142 EUR (336) |
YTD High | date | 35.960 EUR (2024/01/08) |
YTD Low | date | 25.000 EUR (2024/03/07) |
52 Weeks High | date | 61.770 EUR (2023/04/17) |
52 Weeks Low | date | 25.000 EUR (2024/03/07) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/03/28 | 17:42 | 28.43 EUR | 109.64 | 9,699 |
Vienna Stock Exchange | 2024/03/28 | 17:32 | 28.455 EUR | 0.01 | 3 |
Tradegate | 2024/03/28 | 19:35 | 28.525 EUR | 7.22 | 1,348 |
Stuttgart | 2024/03/28 | 19:35 | 28.42 EUR | 1.39 | 265 |
SIX Swiss Exchange | 2023/02/21 | 17:35 | 60.00 EUR | 0.00 | 1 |
SIX Swiss Exchange | 2024/02/26 | 17:35 | 190.00 CHF | 0.00 | 1 |
Munich | 2024/03/28 | 18:48 | 28.485 EUR | 0.06 | 15 |
London Stock Exchange European Trade Reporting | 2024/03/28 | 17:30 | 28.4075 EUR | 4.58 | 10 |
Hanover | 2024/03/28 | 08:16 | 28.505 EUR | 0.00 | 1 |
Hamburg | 2024/03/28 | 17:46 | 28.525 EUR | 0.07 | 16 |
Frankfurt | 2024/03/28 | 19:18 | 28.46 EUR | 0.32 | 59 |
FINRA other OTC Issues | 2024/03/28 | 14:30 | 30.79 USD | 0.24 | 6 |
Euronext Milan MTF Trading After Hours | 2024/03/27 | 18:55 | 28.52 EUR | 0.02 | 6 |
Euronext Milan MTF Global Equity Market | 2024/03/28 | 17:44 | 28.34 EUR | 0.77 | 183 |
Duesseldorf | 2024/03/28 | 19:31 | 28.37 EUR | 0.03 | 10 |
Budapest Stock Exchange | 2024/03/28 | 17:19 | 11,264.00 HUF | 0.14 | 2 |
Bucharest Stock Exchange | 2024/03/28 | 15:03 | 142.70 RON | 0.01 | 5 |
Berlin | 2024/03/28 | 19:10 | 28.43 EUR | 0.01 | 17 |
BX Swiss | 2024/03/28 | 18:00 | 27.762 CHF | 0.01 | 13 |
BAYER AG |
- - |
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen |
Telefon: +49-214-30-1 |
Fax: + |
E-mail: - |
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany. |
Bill Anderson | Chairman of Managing Board |
Heike Prinz | Member of Executive Committee |
Heiko Schipper | Member of Executive Committee |
Rodrigo Santos | Member of Executive Committee |
Stefan Oelrich | Member of Executive Committee |
Wolfgang Nickl | Member of Executive Committee |
Norbert Winkeljohann | Chairman of Supervisory Board |
Barbara Gansewendt | Member of Supervisory Board |
Norbert Bischofberger | Member of Supervisory Board |
Otmar Wiestler | Member of Supervisory Board |
Paul Achleitner | Member of Supervisory Board |
Simone Bagel-Trah | Member of Supervisory Board |
Alberto Weisser | Member of Supervisory Board |
Andrea Sacher | Member of Supervisory Board |
André van Broich | Member of Supervisory Board |
Claudia Schade | Member of Supervisory Board |
Colleen Goggins | Member of Supervisory Board |
Ertharin Cousin | Member of Supervisory Board |
Francesco Grioli | Member of Supervisory Board |
Frank Löllgen | Member of Supervisory Board |
Heike Hausfeld | Member of Supervisory Board |
Heinz Georg Webers | Member of Supervisory Board |
Horst Heinz Paul Baier | Member of Supervisory Board |
Kimberly Marie Lein-Mathisen | Member of Supervisory Board |
Michael Westmeier | Member of Supervisory Board |
Yasmin Fahimi | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer